**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 60702-69-4 |2-Chloro-4-fluorobenzonitrile | 99 | 262-384-8 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 20/21/22 36/37/38
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes, respiratory system and skin.The toxicological
properties of this material have not been fully investigated.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. Harmful if absorbed through the skin. May be
metabolized to cyanide which in turn acts by inhibiting cytochrome
oxidase impairing cellular respiration. Most nitrile compounds are
well absorbed through intact skin, and may cause delayed onset of
symptoms following exposure by this route.
Ingestion:
Harmful if swallowed. May cause gastrointestinal irritation with
nausea, vomiting and diarrhea. The toxicological properties of this
substance have not been fully investigated. Metabolism may release
cyanide, which may result in headache, dizziness, weakness,
collapse, unconsciousness and possible death.
Inhalation:
Harmful if inhaled. Causes respiratory tract irritation. The
toxicological properties of this substance have not been fully
investigated. Inhalation may result in symptoms similar to cyanide
poisoning which include tachypnea, hyperpnea (abnormally rapid or
deep breathing), and dyspnea (labored breathing) followed rapidly by
respiratory depression. Pulmonary edema may occur.
Chronic:
May be metabolized to cyanide which in turn acts by inhibiting
cytochrome oxidase impairing cellular respiration. Exposure to small
amounts of cyanide compounds over long periods of time is reported
to cause loss of appetite, headache, weakness, nausea, dizziness, and
symptoms of irritation of the upper respiratory tract and eyes.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
In case of contact, immediately flush eyes with plenty of water for
at least 15 minutes. Get medical aid.
Skin:
In case of contact, immediately flush skin with plenty of water for
at least 15 minutes while removing contaminated clothing and shoes.
Get medical aid immediately. Wash clothing before reuse.
Ingestion:
If swallowed, do not induce vomiting unless directed to do so by
medical personnel. Never give anything by mouth to an unconscious
person. Get medical aid.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial
respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Approach
fire from upwind to avoid hazardous vapors and toxic decomposition
products. Combustion by-products include oxides of nitrogen and
hydrogen cyanide.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal
container. Clean up spills immediately, observing precautions in the
Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Minimize dust generation and accumulation. Avoid contact with eyes,
skin, and clothing. Keep container tightly closed. Avoid ingestion
and inhalation. Use with adequate ventilation. Wash clothing before
reuse.
Storage:
Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 60702-69-4:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
A respiratory protection program that meets OSHA's 29
CFR 1910.134 and ANSI Z88.2 requirements or European
Standard EN 149 must be followed whenever workplace
conditions warrant respirator use.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Solid
Color: off-white
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 63 - 65 deg C
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C7H3ClFN
Molecular Weight: 155.56
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Dust generation, excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong acids, strong bases.
Hazardous Decomposition Products:
Hydrogen chloride, nitrogen oxides, carbon monoxide, carbon dioxide,
hydrogen fluoride gas, cyanides.
Hazardous Polymerization: Has not been reported
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 60702-69-4 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
2-Chloro-4-fluorobenzonitrile -
Not listed by ACGIH, IARC, or NTP.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
IMO
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
RID/ADR
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing group: III
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 60702-69-4: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 60702-69-4 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 60702-69-4 is not listed on the TSCA inventory.
It is for research and development use only.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 3/25/1999 Revision #3 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
o-Tolyl isocyanate, 99+%
| 614-68-6 |
|
Perfluorodecyl iodide, 97%
| 423-62-1 |
|
3-Phenoxy-1,2-Propanediol, 95%
| 538-43-2 |
|
Ethylenediaminetetraacetic Acid, Trisodium Salt Hydrate, 98%
| 150-38-9 |
|
Ethyl 2-thiopheneacetate, 98%
| 57382-97-5 |
|
4,4'-(Hexafluoroisopropylidene)diphenol, 97%
| 1478-61-1 |
|
2,2,3,3,3-Pentafluoro-1-propanol, 97%
| 422-05-9 |
|
Difluoroacetic Acid, 98%
| 381-73-7 |
|
Fluoroacetonitrile, 99%
| 503-20-8 |
|
3,3,3-Triphenylpropionic Acid, 97%
| 900-91-4 |
|
1-Phenylsemicarbazide
| 103-03-7 |
|
1-Pentyne, 99%
| 627-19-0 |
|
2-Chloropropene, 98%
| 557-98-2 |
|
2,6-Dichlorophenylhydrazine Hydrochloride
| 50709-36-9 |
|
1,2,4,5-Benzenetetracarbonitrile, 99%
| 712-74-3 |
|
4-Nitroguaiacol, 97%
| 3251-56-7 |
|
4,4'-Dinitrobibenzyl, tech., 80%
| 736-30-1 |
|
Ethyl ethoxyacetate, 98%
| 817-95-8 |
|
2,4-Dichloro-5-Sulfamoylbenzoic Acid, 98%
| 2736-23-4 |
|
m-Toluamide, 99%
| 618-47-3 |
|
Methyl 3,5-dinitrobenzoate, 99%
| 2702-58-1 |
|
5-Hydroxyanthranilic acid, 99%
| 394-31-0 |
|
4-Bromo-1,2-(Methylenedioxy)benzene, 97%
| 2635-13-4 |
|
Cis-1,2-Cyclopentanediol, 98%
| 5057-98-7 |
|
Tetramethyl-1,3-Cyclobutanedione, 99%
| 933-52-8 |
|
3-(Isothiocyanatomethyl)-PROXYL, free radical
| 78140-52-0 |
|
4-Undecyloxybenzoic acid, 98%
| 15872-43-2 |
|
Benzyl phenyl ether, 98%
| 945-51-7 |
|
9-Phenyl-9-fluorenol, 99%
| 25603-67-2 |
|
Ethyl cyanoglyoxylate-2-oxime, 97%
| 3849-21-6 |
|
Methyl dichlorophosphate, 97%
| 677-24-7 |
|
Cis-1,2-Cyclohexanediol, 99%
| 1792-81-0 |
|
2-Norbornanecarbonitrile, 98%, Mixture of Endo and Exo
| 2234-26-6 |
|
Hexanes, c.p.
| 110-54-3 |
|
2',4'-Dimethylacetophenone, 96%
| 89-74-7 |
|
3,4-Dimethoxy-3-Cyclobutene-1,2-Dione, 99%
| 5222-73-1 |
|
5-Fluoro-2-methylbenzoic acid, 99%
| 33184-16-6 |
|
6-Fluoro-4-Chromanone, 99%
| 66892-34-0 |
|
beta-D-Lactose, ca 80% beta and 20% alpha
| 5965-66-2 |
|
Phenylmaleic Anhydride, 99%
| 36122-35-7 |
|
Dichloromethylphosphine, tech., 90%
| 676-83-5 |
|
4-Bromo-2,6-Di-Tert-Butylphenol, 98%
| 1139-52-2 |
|
2-Chloro-4-fluorobenzonitrile, 99%
| 60702-69-4 |
|
4,5-Dimethoxy-2-Nitrocinnamic Acid, 97%
| 20567-38-8 |
|
4-Hydroxy-2(5h)-furanone, 98%
| 541-57-1 |
|
Diethyl meso-2,5-dibromoadipate
| 869-10-3 |
|
2-Methyl-6-isopropylaniline, 97%
| 5266-85-3 |
|
1,8-Diphenyl-1,3,5,7-octatetraene
| 3029-40-1 |
|
3-Cyanoindole, 98%
| 5457-28-3 |
|
Methyl 4-(bromomethyl)benzoate, 98%
| 2417-72-3 |
|
|